scabies
SCABIES
Scabies is a contagious disease caused by the mite Sarcoptes scabiei var hominis.
The affected individual usually complains of having a highly pruritic rash that occurs at night.
It occurs more often in children <15 years of age, sexually active young adults, the immunocompromised and in persons living in crowded living conditions (eg nursing homes, military barracks).
Transmission is typically by direct skin contact with an infected person and in adults, sexual transmission is common.

Introduction

  • Diagnosis is made based on clinical presentation & can be confirmed by microscopic identification of mites, eggs or mite feces
  • Scabies should be suspected in a patient who presents w/ a highly pruritic rash w/ nocturnal predominance
    • Scabies is highly suggested if there is also a history of contact w/ an infected person or if there is a history of contact w/ family member or sexual partner who has pruritic lesions w/ nocturnal predominance
  • Scabies is caused by the mite: Sarcoptes scabiei var hominis

Signs and Symptoms

Clinical Presentation

  • Occurs more often in children <15 yr, sexually active young adults, the immunocompromised & in persons living in crowded living conditions (eg nursing homes, military barracks)
  • Transmission is typically by direct skin contact w/ an infected person & in adults, sexual transmission is common
    • Though there is limited documentation, transmission by fomites may be possible (esp in cases of crusted scabies where a large amt of parasites are involved)
    • The mites can live for up to 30 days on a host & remain alive for 3 days on furniture, bedding etc
Signs & Symptoms
  • Primary symptom is generalized pruritus, which is usually worse at night
    • Pruritus is caused by a hypersensitivity reaction to the mite & its products (saliva, eggs & feces) once the host becomes sensitized
    • Hypersensitivity occurs 4-6 wk after infestation but occurs in 1-4 days w/ re-infestation because the host has been previously sensitized
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, Yesterday

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 2 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
5 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.